VALIANTLABNSEValiant Laboratories LimitedMediumNeutral
Announced Tue, 26 May · 15:01 IST

Santosh Vora has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹77.90
prior close
₹81.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.0-0.0+2.7+1.9+2.1-2.0-4.4-5.6-14.3-14.6-20.4
Up moveDown movePending
AI summary

Santosh Shantilal Vora, a promoter of Valiant Laboratories Limited, has filed a Regulation 31(4) disclosure confirming that as of March 31, 2026, the promoter group collectively holds 4,07,01,487 equity shares. The disclosure lists individual promoter and promoter group holdings including Santosh Vora (40,73,987 shares), Shantilal Vora (40,73,987 shares), Dhanvallabh Ventures LLP (2,54,37,500 shares), and others. The filing explicitly states that no encumbrance (pledge) has been created or invoked on the shares held by the promoter group. This is a routine annual disclosure requirement under SEBI takeover regulations.

Likely market impact

The disclosure confirms no change in promoter shareholding structure and that shares are not pledged, which is a positive indicator of promoter commitment. This routine filing should have no immediate impact on the stock price.